Viewing Study NCT02419820


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-02-02 @ 7:31 AM
Study NCT ID: NCT02419820
Status: TERMINATED
Last Update Posted: 2019-02-15
First Post: 2015-01-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-escalation, Repeated and Single Oral Dosing Study
Sponsor: IlDong Pharmaceutical Co Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ID-TMG-102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View